Roivant Sciences Ltd. (ROIV) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 13 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ROIV is $31.50, representing a +8.2% upside from the current price of $29.12. Price targets range from a low of $30.00 to a high of $34.00.
